Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer's disease.
Saved in:
| Title: | Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer's disease. |
|---|---|
| Authors: | Vermunt L; Alzheimer center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Programme Neurodegeneration, Amsterdam University Medical Centers, Vrije Universiteit, 1081 HZ Amsterdam, The Netherlands.; Neurochemistry Laboratory, Departmentt of Laboratory Medicine, Amsterdam Neuroscience, Programme Neurodegeneration, Amsterdam University Medical Centers, Vrije Universiteit, 1081 HZ Amsterdam, The Netherlands., Sutphen CL; Washington University School of Medicine, St. Louis, MO 63110, USA., Dicks E; Alzheimer center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Programme Neurodegeneration, Amsterdam University Medical Centers, Vrije Universiteit, 1081 HZ Amsterdam, The Netherlands.; Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA., de Leeuw DM; Alzheimer center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Programme Neurodegeneration, Amsterdam University Medical Centers, Vrije Universiteit, 1081 HZ Amsterdam, The Netherlands., Allegri RF; Instituto de Investigaciones Neurológicas FLENI, Buenos Aires, Argentina., Berman SB; Department of Neurology, Alzheimer's Disease Research Center, and Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15213, USA., Cash DM; Dementia Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3AR, UK., Chhatwal JP; Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA., Cruchaga C; Washington University School of Medicine, St. Louis, MO 63110, USA., Day GS; Mayo Clinic Florida, Jacksonville, FL 32224, USA., Ewers M; Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilian-University Munich, 81377 Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), 37075 Göttingen, Germany., Farlow MR; Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN 46202, USA., Fox NC; Dementia Research Institute at UCL, University College London Institute of Neurology, London W1T 7NF, UK.; Department of Neurodegenerative Disease, Dementia Research Centre, London WC1N 3AR, UK., Ghetti B; Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, 72076 Tübingen, Germany., Graff-Radford NR; Mayo Clinic Florida, Jacksonville, FL 32224, USA., Hassenstab J; Washington University School of Medicine, St. Louis, MO 63110, USA., Jucker M; German Center for Neurodegenerative Diseases (DZNE), 37075 Göttingen, Germany.; Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, 72076 Tübingen, Germany., Karch CM; Washington University School of Medicine, St. Louis, MO 63110, USA., Kuhle J; Neurologic Clinic and Policlinic, University Hospital and University Basel, 4031 Basel, Switzerland., Laske C; German Center for Neurodegenerative Diseases (DZNE), 37075 Göttingen, Germany.; Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, 72076 Tübingen, Germany., Levin J; German Center for Neurodegenerative Diseases (DZNE), 37075 Göttingen, Germany.; Ludwig-Maximilians-Universität München, D-80539 München, Germany., Masters CL; Florey Institute, Melbourne, Parkville Vic 3052, Australia.; The University of Melbourne, Melbourne, Parkville Vic 3052, Australia., McDade E; Washington University School of Medicine, St. Louis, MO 63110, USA., Mori H; Department of Clinical Neuroscience, Osaka City University Medical School, 558-8585 Osaka, Japan., Morris JC; Washington University School of Medicine, St. Louis, MO 63110, USA., Perrin RJ; Washington University School of Medicine, St. Louis, MO 63110, USA., Preische O; German Center for Neurodegenerative Diseases (DZNE), 37075 Göttingen, Germany.; Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, 72076 Tübingen, Germany., Schofield PR; Neuroscience Research Australia & School of Medical Sciences, NSW 2052 Sydney, Sydney, Australia., Suárez-Calvet M; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, 08005 Barcelona, Spain.; IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.; Servei de Neurologia, Hospital del Mar, 08003 Barcelona, Spain., Xiong C; Washington University School of Medicine, St. Louis, MO 63110, USA., Scheltens P; Alzheimer center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Programme Neurodegeneration, Amsterdam University Medical Centers, Vrije Universiteit, 1081 HZ Amsterdam, The Netherlands.; Life Science Partners, 1071 DV Amsterdam, The Netherlands., Teunissen CE; Neurochemistry Laboratory, Departmentt of Laboratory Medicine, Amsterdam Neuroscience, Programme Neurodegeneration, Amsterdam University Medical Centers, Vrije Universiteit, 1081 HZ Amsterdam, The Netherlands., Visser PJ; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, 6229 ER Maastricht, Netherlands., Bateman RJ; Washington University School of Medicine, St. Louis, MO 63110, USA., Benzinger TLS; Washington University School of Medicine, St. Louis, MO 63110, USA., Fagan AM; Washington University School of Medicine, St. Louis, MO 63110, USA., Gordon BA; Washington University School of Medicine, St. Louis, MO 63110, USA., Tijms BM; Alzheimer center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Programme Neurodegeneration, Amsterdam University Medical Centers, Vrije Universiteit, 1081 HZ Amsterdam, The Netherlands. |
| Source: | Brain communications [Brain Commun] 2024 Oct 09; Vol. 6 (5), pp. fcae357. Date of Electronic Publication: 2024 Oct 09 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755125 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-1297 (Electronic) Linking ISSN: 26321297 NLM ISO Abbreviation: Brain Commun Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2632-1297 |
|---|---|
| DOI: | 10.1093/braincomms/fcae357 |
